Enfusion, Inc. (NYSE:ENFN – Get Free Report) saw a significant increase in short interest during the month of September. As of September 15th, there was short interest totalling 1,750,000 shares, an increase of 36.7% from the August 31st total of 1,280,000 shares. Currently, 4.1% of the shares of the company are short sold. Based on […]
Enfusion, Inc. (NYSE:ENFN – Get Free Report) was the target of a significant growth in short interest in September. As of September 15th, there was short interest totalling 1,750,000 shares, a growth of 36.7% from the August 31st total of 1,280,000 shares. Approximately 4.1% of the company’s stock are short sold. Based on an average […]
Enfusion, Inc. (NYSE:ENFN – Get Free Report) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 1,280,000 shares, a growth of 5.8% from the August 15th total of 1,210,000 shares. Based on an average trading volume of 409,200 shares, the days-to-cover ratio is […]
Enfusion (NYSE:ENFN – Free Report) had its price target reduced by Morgan Stanley from $12.00 to $11.00 in a report released on Wednesday, Benzinga reports. Morgan Stanley currently has an overweight rating on the stock. Several other brokerages have also commented on ENFN. The Goldman Sachs Group decreased their price target on Enfusion from $11.50 […]
Enfusion (NYSE:ENFN – Get Free Report) is set to release its earnings data before the market opens on Tuesday, August 8th. Analysts expect Enfusion to post earnings of $0.05 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Enfusion (NYSE:ENFN – Get […]